Traws Pharma (TRAW) Misses Q2 EPS by 11c

Traws Pharma (NASDAQ: TRAW) reported Q2 EPS of ($0.11). Revenue for the quarter came in at $2.73 million.

For earnings history and earnings-related data on Traws Pharma (TRAW) click here.

You May Also Be Interested In

• Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
• SK Hynix (SKHY) call put ratio 1.1 calls to 1 put as share price up 2.6%
• Toronto Realtor Sam Kamra Says Some Homeowners Planning to Sell Within 3 Years Should Consider Selling Now and Renting Instead